Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07115862 · ClinicalTrials.gov registry record · NA
Effects of Pomegranate Juice on Ulcerative Colitis
A NA study of Ulcerative Colitis (Disorder), sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT07115862: Recruiting NA study of Ulcerative Colitis (Disorder), sponsored by University of California, Los Angeles.
NCT07115862 is a NA study of Ulcerative Colitis (Disorder) that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07115862, a NA study of Ulcerative Colitis (Disorder), is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether consumption of 237 ml of pomegranate juice daily for 8 weeks will: 1. lower inflammation (in the gut as well as generally in the body) and improve your overall quality of life 2. affect the microbes living in the gut (gut microbiota)
Primary Outcome
Simple Clinical Colitis Activity Index (SCCAI) includes questions about bowel frequency, urgency of defecation, etc. Measured by the number of points/scores.
Conditions Studied
Interventions
- OTHER pomegranate juice -> habitual diet
- OTHER habitual diet -> pomegranate juice
Study Locations (2)
California
- West Los Angeles VA Medical Center - Los Angeles
- UCLA Center for Human Nutrition - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2027-10-15 |
| Phase | NA |
What NCT07115862 shows while recruiting
NCT07115862 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Ulcerative Colitis (Disorder) appearing as the primary indexed condition, and to 2 interventions - of which pomegranate juice -> habitual diet is the first listed.
NCT07115862 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07115862 about?
NCT07115862 is a clinical study titled "Effects of Pomegranate Juice on Ulcerative Colitis". The purpose of this study is to determine whether consumption of 237 ml of pomegranate juice daily for 8 weeks will: 1. lower inflammation (in the gut as well as generally in the body) and improve your overall quality of life 2. affect the microbes living in the gut (gut microbiota)
What is the current status of trial NCT07115862?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-15. Estimated completion is 2027-10-15.
What conditions does trial NCT07115862 study?
This clinical trial studies the following conditions: Ulcerative Colitis (Disorder).
What interventions are being tested in trial NCT07115862?
The interventions under investigation include: pomegranate juice -> habitual diet (OTHER), habitual diet -> pomegranate juice (OTHER).
Who is sponsoring clinical trial NCT07115862?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07115862 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis (Disorder)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07115862's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI